Investor Relations
Corporate Profile
Arcutis Biotherapeutics (NASDAQ: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.
The company’s strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders.
Latest Quarterly Earnings
News
Nov 23, 2020
Nov 11, 2020
Nov 05, 2020
Events
Nov 23, 2020 at 8:30 AM EST
Nov 18, 2020 at 12:20 PM PST
Sep 29, 2020 at 8:30 AM EDT